@fabdelmontana https://t.co/PpT0wFFp1U Si de mars à mai en France métropolitaine, une vague de surmortalité a frappé, attendons nous à une 2ieme vague (pas celle que ignorant nous prédit), celle de la fibrose pulmonaire ; autrement plus cruelle par sa len
@smlungpathguy @howardm19 @yro854 @JeffreyKanneMD @DrTravisScott @6Patterns @jonherochung Also I think you mean FVC ;-). This is a call to treat. Of course the trials are in highly selected patients. Presence of symptoms probably is the deciding factor
RT @ild_inn: IPF is a progressive lung disease, prompt treatment is important along with effective side effect management, education and do…
RT @ild_inn: IPF is a progressive lung disease, prompt treatment is important along with effective side effect management, education and do…
IPF is a progressive lung disease, prompt treatment is important along with effective side effect management, education and dose reduction if needed. https://t.co/PgclTBs4we
RT @DrPujaMehta1: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @T…
RT @DrPujaMehta1: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @T…
RT @DrPujaMehta1: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @T…
RT @DrPujaMehta1: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @T…
RT @DrPujaMehta1: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @T…
RT @DrPujaMehta1: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @T…
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat | Respiratory Research | Full Text Nice review @TobyMMaher in resp res @leticiakawano @IPFdoc @EuroRespSoc @ild_inn https://t.co/3sFGIbtG7K
Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat https://t.co/XacgcYEjrB
🧞♂️🧞♂️🧞♂️ #antifibrotic #IPF https://t.co/0yOT7IKbM0
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
RT @ild_inn: Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
Prompt treatment of IPF essential in preserving patients lung function. https://t.co/PgclTBs4we
New article: Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat https://t.co/6bre0Whz3B
#respiratoryresearch Antifibrotic therapy for idiopathic pulmonary fibrosis: time to treat https://t.co/6gD0TSaX9C